The second strategic reperfusion early after myocardial infarction (STREAM-2) study

Eur Heart J Acute Cardiovasc Care. 2023 Apr 17;12(4):219-221. doi: 10.1093/ehjacc/zuad024.

Authors

Venu Menon¹, Sigrun Halvorsen²

Affiliations

¹ Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
² Department of Cardiology, Oslo University Hospital, Ulleval, Postboks 4956, 0424 Oslo, Norway.

PMID: 36895183
DOI: 10.1093/ehjacc/zuad024

No abstract available

MeSH terms

Fibrinolytic Agents / therapeutic use
Humans
Myocardial Infarction* / drug therapy
Myocardial Infarction* / therapy
Myocardial Reperfusion
Reperfusion

Substances

Fibrinolytic Agents